BioCentury
ARTICLE | Clinical News

Natesto regulatory update

June 2, 2014 7:00 AM UTC

FDA approved an NDA from Trimel for Natesto to treat testosterone deficiency. The company said it has not yet established a launch date or pricing for the product. In January, FDA extended by 3 months...